About this Journal Submit a Manuscript Table of Contents
Pain Research and Treatment
Volume 2012 (2012), Article ID 653714, 11 pages
http://dx.doi.org/10.1155/2012/653714
Review Article

A Comprehensive Evaluation of Standardized Assessment Tools in the Diagnosis of Fibromyalgia and in the Assessment of Fibromyalgia Severity

Boomershine Wellness Centers, Vanderbilt University, 125 Cool Springs Boulevard, Suite 240, Franklin, TN 37067-6475, USA

Received 5 May 2011; Accepted 27 July 2011

Academic Editor: Mary-Ann Fitzcharles

Copyright © 2012 Chad S. Boomershine. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Bazzichi, A. Rossi, C. Giacomelli, and S. Bombardieri, “Exploring the abyss of fibromyalgia biomarkers,” Clinical and Experimental Rheumatology, vol. 28, supplement 63, pp. S125–S130, 2010.
  2. P. J. Mease, L. M. Arnold, L. J. Crofford et al., “Identifying the clinical domains of fibromyalgia: contributions from clinician and patient delphi exercises,” Arthritis and Rheumatism, vol. 59, no. 7, pp. 952–960, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. F. Wolfe, H. A. Smythe, M. B. Yunus et al., “The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee,” Arthritis and Rheumatism, vol. 33, no. 2, pp. 160–172, 1990. View at Scopus
  4. R. S. Katz, F. Wolfe, and K. Michaud, “Fibromyalgia diagnosis: a comparison of clinical, survey, and American College of Rheumatology criteria,” Arthritis and Rheumatism, vol. 54, no. 1, pp. 169–176, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. F. Wolfe, D. J. Clauw, M. Fitzcharles et al., “The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity,” Arthritis Care and Research, vol. 62, no. 5, pp. 600–610, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. M. E. Robinson, “The provisional diagnostic criteria for fibromyalgia: one step forward, two steps back,” Arthritis Care and Research, vol. 62, no. 11, pp. 1675–1676, 2010.
  7. K. Toda, “Preliminary diagnostic criteria for fibromyalgia should be partially revised,” Arthritis Care and Research, vol. 63, no. 2, pp. 308–309, 2011. View at Publisher · View at Google Scholar · View at PubMed
  8. E. N. Thompson, “Diagnostic criteria for fibromyalgia: comment on the article by Wolfe et al,” Arthritis Care and Research, vol. 62, no. 11, pp. 1674–1675, 2010.
  9. D. L. Goldenberg, D. Clauw, M. Fitzcharles, et al., “How to use the new ACR Fibromyalgia diagnostic criteria,” Arthritis Care and Research, vol. 63, no. 7, pp. 1073–1074, 2011. View at Publisher · View at Google Scholar · View at PubMed
  10. A. Okifuji, D. C. Turk, J. D. Sinclair, T. W. Starz, and D. A. Marcus, “A standardized manual tender point survey. I. Development and determination of a threshold point for the identification of positive tender points in fibromyalgia syndrome,” Journal of Rheumatology, vol. 24, no. 2, pp. 377–383, 1997. View at Scopus
  11. S. F. Carville, S. Arendt-Nielsen, H. Bliddal et al., “EULAR evidence-based recommendations for the management of fibromyalgia syndrome,” Annals of the Rheumatic Diseases, vol. 67, no. 4, pp. 536–541, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. P. J. Mease, L. M. Arnold, E. H. Choy et al., “Fibromyalgia syndrome module at OMERACT 9: domain construct,” Journal of Rheumatology, vol. 36, no. 10, pp. 2318–2329, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. E. H. Choy, L. M. Arnold, D. J. Clauw et al., “Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome,” Journal of Rheumatology, vol. 36, no. 10, pp. 2330–2334, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. S. F. Carville and E. H. Choy, “Systematic review of discriminating power of outcome measures used in clinical trials of fibromyalgia,” Journal of Rheumatology, vol. 35, no. 11, pp. 2094–2105, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. R. H. Dworkin, D. C. Turk, K. W. Wyrwich et al., “Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations,” Journal of Pain, vol. 9, no. 2, pp. 105–121, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. C. S. Cleeland and K. M. Ryan, “Pain assessment: global use of the Brief Pain Inventory,” Annals of the Academy of Medicine Singapore, vol. 23, no. 2, pp. 129–138, 1994. View at Scopus
  17. R. D. Kerns, D. C. Turk, and T. E. Rudy, “The west haven-yale multidimensional pain inventory (WHYMPI),” Pain, vol. 23, no. 4, pp. 345–356, 1985. View at Scopus
  18. C. S. Burckhardt, S. R. Clark, and R. M. Bennett, “The fibromyalgia impact questionnaire: development and validation,” Journal of Rheumatology, vol. 18, no. 5, pp. 728–733, 1991. View at Scopus
  19. F. Wolfe, D. J. Hawley, D. L. Goldenberg, I. J. Russell, D. Buskila, et al., “The assessment of functional impairment in fibromyalgia (FM): rasch analyses of 5 functional scales and the development of the FM health assessment questionnaire,” Journal of Rheumatology, vol. 27, no. 8, pp. 1989–1999, 2000. View at Scopus
  20. R. M. Bennett, R. Friend, K. D. Jones, R. Ward, B. K. Han, et al., “The revised fibromyalgia impact questionnaire (FIQR): validation and psychometric properties,” Arthritis Research and Therapy, vol. 11, no. 4, Article ID R120, 2009. View at Publisher · View at Google Scholar · View at PubMed
  21. W. Guy, ECDEU Assessment Manual for Psychopharmacology, Government Printing Office, Washington, DC, USA, 1976.
  22. M. Le Gal, Y. Mainguy, K. Le Lay, A. Nadjar, D. Allain, et al., “Linguistic validation of six patient-reported outcomes instruments into 12 languages for patients with fibromyalgia,” Joint Bone Spine, vol. 77, no. 2, pp. 165–170, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. A. T. Beck, C. H. Ward, M. Mendelsohn, J. Mock, and J. Erbaugh, “An inventory for measuring depression,” Archives of General Psychiatry, vol. 4, pp. 561–571, 1961. View at Scopus
  24. A. T. Beck, R. A. Steer, R. Ball, and W. F. Ranieri, “Comparison of Beck depression inventories -IA and -II in psychiatric outpatients,” Journal of Personality Assessment, vol. 67, no. 3, pp. 588–597, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. C. S. Burckhardt, C. A. O'Reilly, A. N. Wiens, S. R. Clark, S. M. Campbell, et al., “Assessing depression in fibromyalgia patients,” Arthritis Care and Research, vol. 7, no. 1, pp. 35–39, 1994. View at Scopus
  26. A. G. Blouin, E. L. Perez, and J. H. Blouin, “Computerized administration of the diagnostic interview schedule,” Psychiatry Research, vol. 23, no. 3, pp. 335–344, 1988. View at Publisher · View at Google Scholar · View at Scopus
  27. H. P. Erdman, M. H. Klein, J. H. Greist et al., “A comparison of two computer-administered versions of the NIMH diagnostic interview schedule,” Journal of Psychiatric Research, vol. 26, no. 1, pp. 85–95, 1992. View at Publisher · View at Google Scholar · View at Scopus
  28. A. T. Beck, R. A. Steer, and M. G. Garbin, “Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation,” Clinical Psychology Review, vol. 8, no. 1, pp. 77–100, 1988. View at Scopus
  29. A. B. Shafer, “Meta-analysis of the factor structures of four depression questionnaires: beck, CES-D, Hamilton, and Zung,” Journal of Clinical Psychology, vol. 62, no. 1, pp. 123–146, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. R. A. Steer, R. Ball, and W. F. Ranieri, “Dimensions of the Beck Depression Inventory-II in clinically depressed outpatients,” Journal of Clinical Psychology, vol. 55, no. 1, pp. 117–128, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. A. S. Zigmond and R. P. Snaith, “The hospital anxiety and depression scale,” Acta Psychiatrica Scandinavica, vol. 67, no. 6, pp. 361–370, 1983. View at Scopus
  32. I. Bjelland, A. A. Dahl, T. T. Haug, and D. Neckelmann, “The validity of the hospital anxiety and depression scale: an updated literature review,” Journal of Psychosomatic Research, vol. 52, no. 2, pp. 69–77, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Herrmann, “International experiences with the hospital anxiety and depression scale- a review of validation data and clinical results,” Journal of Psychosomatic Research, vol. 42, no. 1, pp. 17–41, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. S. A. Epstein, G. Kay, D. Clauw et al., “Psychiatric disorders in patients with fibromyalgia: a multicenter investigation,” Psychosomatics, vol. 40, no. 1, pp. 57–63, 1999. View at Scopus
  35. E. A. Malt, J. E. Berle, S. Olafsson, A. Lund, and H. Ursin, “Fibromyalgia is associated with panic disorder and functional dyspepsia with mood disorders: a study of women with random sample population controls,” Journal of Psychosomatic Research, vol. 49, no. 5, pp. 285–289, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. J. M. Glass, “Review of cognitive dysfunction in fibromyalgia: a convergence on working memory and attentional control impairments,” Rheumatic Disease Clinics of North America, vol. 35, no. 2, pp. 299–311, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. M. Seidenberg, A. Haltiner, M. A. Taylor, B. B. Hermann, and A. Wyler, “Development and validation of a Multiple Ability Self-Report Questionnaire,” Journal of Clinical and Experimental Neuropsychology, vol. 16, no. 1, pp. 93–104, 1994. View at Scopus
  38. S. T. Farias, D. Mungas, and W. Jagust, “Degree of discrepancy between self and other-reported everyday functioning by cognitive status: dementia, mild cognitive impairment, and healthy elders,” International Journal of Geriatric Psychiatry, vol. 20, no. 9, pp. 827–834, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. E. M. Smets, B. Garssen, B. Bonke, and J. C. De Haes, “The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue,” Journal of Psychosomatic Research, vol. 39, no. 3, pp. 315–325, 1995. View at Publisher · View at Google Scholar · View at Scopus
  40. B. B. Tack, “Fatigue in rheumatoid arthritis: conditions, strategies, and consequences,” Arthritis Care and Research, vol. 3, no. 2, pp. 65–70, 1990. View at Scopus
  41. L. B. Krupp, N. G. LaRocca, J. Muir-Nash, and A. D. Steinberg, “The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus,” Archives of Neurology, vol. 46, no. 10, pp. 1121–1123, 1989. View at Scopus
  42. A. Ericsson and K. Mannerkorpi, “Assessment of fatigue in patients with fibromyalgia and chronic widespread pain. Reliability and validity of the Swedish version of the MFI-20,” Disability and Rehabilitation, vol. 29, no. 22, pp. 1665–1670, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. J. S. Lin, D. J. Brimmer, E. M. Maloney, E. Nyarko, R. BeLue, and W. C. Reeves, “Further validation of the Multidimensional Fatigue Inventory in a US adult population sample,” Population Health Metrics, vol. 7, article 18, 2009. View at Publisher · View at Google Scholar · View at PubMed
  44. F. Wolfe, S. Martin, and A. Sesti, “The assessment of fatigue: a comparative study of 3 assessment instruments in patients with fibromyalgia,” Annals of the Rheumatic Diseases, vol. 61, supplement 1, p. 49, 2002.
  45. N. H. Hjollund, J. H. Andersen, and P. Bech, “Assessment of fatigue in chronic disease: a bibliographic study of fatigue measurement scales,” Health and Quality of Life Outcomes, vol. 5, article 12, 2007. View at Publisher · View at Google Scholar · View at PubMed
  46. R. R. Taylor, L. A. Jason, and A. Torres, “Fatigue rating scales: an empirical comparison,” Psychological Medicine, vol. 30, no. 4, pp. 849–856, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Gencay-Can and S. S. Can, “Validation of the Turkish version of the fatigue severity scale in patients with fibromyalgia,” Rheumatology International. In press. View at Publisher · View at Google Scholar · View at PubMed
  48. A. J. Dittner, S. C. Wessely, and R. G. Brown, “The assessment of fatigue: a practical guide for clinicians and researchers,” Journal of Psychosomatic Research, vol. 56, no. 2, pp. 157–170, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. L. Whitehead, “The measurement of fatigue in chronic illness: a systematic review of unidimensional and multidimensional fatigue measures,” Journal of Pain and Symptom Management, vol. 37, no. 1, pp. 107–128, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. J. Avina-Zubieta, G. S. Alarcon, H. A. Bischoff-Ferrari et al., “Measurement of fatigue in systemic lupus erythematosus: a systematic review,” Arthritis and Rheumatism, vol. 57, no. 8, pp. 1348–1357, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. J. H. Friedman, G. Alves, P. Hagell et al., “Fatigue rating scales critique and recommendations by the movement disorders society task force on rating scales for Parkinson's disease,” Movement Disorders, vol. 25, no. 7, pp. 805–822, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. P. R. Dunkl, A. G. Taylor, G. G. McConnell, A. P. Alfano, and M. R. Conaway, “Responsiveness of fibromyalgia clinical trial outcome measures,” Journal of Rheumatology, vol. 27, no. 11, pp. 2683–2691, 2000. View at Scopus
  53. R. Friend and R. M. Bennett, “Distinguishing fibromyalgia from rheumatoid arthritis and systemic lupus in clinical questionnaires: an analysis of the revised Fibromyalgia Impact Questionnaire (FIQR) and its variant, the Symptom Impact Questionnaire (SIQR), along with pain locations,” Arthritis Research and Therapy, vol. 13, no. 2, Article ID R58, 2011. View at Publisher · View at Google Scholar · View at PubMed
  54. R. D. Hays, S. A. Martin, A. M. Sesti, and K. L. Spritzer, “Psychometric properties of the medical outcomes study sleep measure,” Sleep Medicine, vol. 6, no. 1, pp. 41–44, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. T. E. Weaver, A. M. Laizner, L. K. Evans et al., “An instrument to measure functional status outcomes for disorders of excessive sleepiness,” Sleep, vol. 20, no. 10, pp. 835–843, 1997. View at Scopus
  56. C. D. Jenkins, B. A. Stanton, S. Niemcryk, and R. M. Rose, “A scale for the estimation of sleep problems in clinical research,” Journal of Clinical Epidemiology, vol. 41, no. 4, pp. 313–321, 1988. View at Scopus
  57. A. Sadosky, E. Dukes, and C. Evans, “Reliability of a 1-week recall period for the Medical Outcomes Study Sleep Scale (MOS-SS) in patients with fibromyalgia,” Health and Quality of Life Outcomes, vol. 7, article 12, 2009. View at Publisher · View at Google Scholar · View at PubMed
  58. S. Martin, A. Chandran, L. Zografos, and G. Zlateva, “Evaluation of the impact of fibromyalgia on patients' sleep and the content validity of two sleep scales,” Health and Quality of Life Outcomes, vol. 7, article 64, 2009. View at Publisher · View at Google Scholar · View at PubMed
  59. B. K. Crawford, E. C. Piault, C. Lai, and P. Sarzi-Puttini, “Assessing sleep in fibromyalgia: investigation of an alternative scoring method for the Jenkins Sleep Scale based on data from randomised controlled studies,” Clinical and Experimental Rheumatology, vol. 28, supplement 63, pp. S100–S109, 2010.
  60. R. E. Harris, R. H. Gracely, S. A. McLean et al., “Comparison of clinical and evoked pain measures in fibromyalgia,” Journal of Pain, vol. 7, no. 7, pp. 521–527, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. F. Wolfe, “The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic,” Annals of the Rheumatic Diseases, vol. 56, no. 4, pp. 268–271, 1997. View at Scopus
  62. F. Petzke, R. H. Gracely, K. M. Park, K. Ambrose, and D. J. Clauw, “What do tender points measure? Influence of distress on 4 measures of tenderness,” Journal of Rheumatology, vol. 30, no. 3, pp. 567–574, 2003. View at Scopus
  63. L. J. Crofford, M. C. Rowbotham, P. J. Mease et al., “Pregabalin for the treatment of Fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial,” Arthritis and Rheumatism, vol. 52, no. 4, pp. 1264–1273, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. M. B. Scharf, M. Baumann, and D. V. Berkowitz, “The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia,” Journal of Rheumatology, vol. 30, no. 5, pp. 1070–1074, 2003. View at Scopus
  65. D. Cella, S. Yount, N. Rothrock et al., “The patient-reported outcomes measurement information system (PROMIS): progress of an NIH roadmap cooperative group during its first two years,” Medical Care, vol. 45, no. 5, pp. S3–S11, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. D. Cella, W. Riley, A. Stone et al., “The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008,” Journal of Clinical Epidemiology, vol. 63, no. 11, pp. 1179–1194, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. C. R. Soldatos, D. G. Dikeos, and T. J. Paparrigopoulos, “Athens Insomnia Scale: validation of an instrument based on ICD-10 criteria,” Journal of Psychosomatic Research, vol. 48, no. 6, pp. 555–560, 2000. View at Publisher · View at Google Scholar · View at Scopus
  68. G. A. Wells, T. Li, J. R. Kirwan et al., “Assessing quality of sleep in patients with rheumatoid arthritis,” Journal of Rheumatology, vol. 36, no. 9, pp. 2077–2086, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. J. T. Farrar, J. P. Young Jr., L. LaMoreaux, J. L. Werth, and R. M. Poole, “Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale,” Pain, vol. 94, no. 2, pp. 149–158, 2001. View at Publisher · View at Google Scholar · View at Scopus
  70. C. S. Boomershine, “The FIBRO System: a rapid strategy for assessment and management of fibromyalgia syndrome,” Therapeutic Advances in Musculoskeletal Disease, vol. 2, no. 4, pp. 187–200, 2010.